⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HUMA News
Humacyte, Inc. Common Stock
Rain the Growth Agency Launches Pro Bono Creative Campaign for GlamourGals
prnewswire.com
SHOP
HUMA
FLWS
SheScales Welcomes Three Bold Female-Founded Brands to Its 2025-2026 Cohort
prnewswire.com
SHOP
HUMA
FLWS
Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results
globenewswire.com
HUMA
Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium)
globenewswire.com
HUMA
Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
HUMA
Humacyte Announces Presentation of Positive Two-Year Results from Phase 3 Dialysis Access Trial at the American Society of Nephrology’s Kidney Week 2025
globenewswire.com
HUMA
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025
globenewswire.com
HUMA
Humacyte Announces Publication of New Data Comparing Symvess™ to Autologous Vein in Extremity Arterial Trauma
globenewswire.com
HUMA
D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering
accessnewswire.com
HUMA
HUMA
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
globenewswire.com
HUMA